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A B S T R A C T
The late president of the Palestinian Authority, Yasser Arafat, died in November 2004 in Percy Hospital,
one month after having experienced a sudden onset of symptoms that included severe nausea, vomiting,
diarrhoea and abdominal pain and which were followed by multiple organ failure. In spite of numerous
investigations performed in France, the pathophysiological mechanisms at the origin of the symptoms
could not be identiﬁed. In 2011, we found abnormal levels of polonium-210 (210Po) in some of Arafat’s
belongings that were worn during his ﬁnal hospital stay and which were stained with biological ﬂuids.
This ﬁnding led to the exhumation of Arafat’s remains in 2012. Signiﬁcantly higher (up to 20 times)
activities of 210Po and lead-210 (210Pb) were found in the ribs, iliac crest and sternum specimens
compared to reference samples from the literature (p-value <1%). In all specimens from the tomb, 210Po
activity was supported by a similar activity of 210Pb. Biokinetic calculations demonstrated that a 210Pb
impurity, as identiﬁed in a commercial source of 3 MBq of 210Po, may be responsible for the activities
measured in Arafat’s belongings and remains 8 years after his death. The absence of myelosuppression
and hair loss in Mr Arafat’s case compared to Mr Litvinenko’s, the only known case of malicious poisoning
with 210Po, could be explained by differences in the time delivery-scheme of intake. In conclusion,
statistical Bayesian analysis combining all the evidence gathered in our forensic expert report
moderately supports the proposition that Mr Arafat was poisoned by 210Po.
 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The following presentation of the background events leading to
President Yasser Arafat’s death is based on the reading and analysis
of the medical records provided to us by Mrs Suha Arafat, widow of
Yasser Arafat and next of kin [1].
President Arafat was born on August 4th, 1929. For over three
years prior to his death, he remained secluded in the quarters of the
Palestinian Authority in Ramallah. He was said to be in general
good health, and did not drink alcohol or smoke tobacco. On the
evening of October 12th, 2004, approximately four hours after a
meal, Yasser Arafat experienced severe nausea, vomiting, and
abdominal pain followed by watery diarrhoea. On October 25th,* Corresponding author at: Institute of Radiation Physics, Lausanne University
Hospital, Lausanne, Switzerland. Tel.: +41 213148142.
E-mail address: francois.bochud@chuv.ch (F. Bochud).
http://dx.doi.org/10.1016/j.forsciint.2015.09.019
0379-0738/ 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access 
nd/4.0/).2004, a bone marrow aspiration analyzed in Tunis showed a well
populated bone marrow with mild myelodysplastic changes, the
presence of megakaryocytes and an increased number of macro-
phages with hemophagocytic changes. An infectious work-up,
including blood, fecal and urine cultures and an immunological
evaluation were considered as normal. On October 29th, 2004,
President Yasser Arafat was transferred to the French Military
Hospital of Percy in Clamart, France. At the time he arrived in France,
the diagnostic list included inﬂammatory enterocolitis, severe
disseminated intravascular coagulation (DIC) with signiﬁcant
thrombocytopenia and bone marrow hemophagocytosis. Shortly
after admission, the patient developed liver problems with
cholestatic jaundice. The patient did not develop fever and the
infectious work-ups, including AIDS tests, remained negative. All the
microbiological investigations, as well as a urine test for the
presence of gamma ray emitting radionuclides, were negative.
Infectious, autoimmune or vascular processes, as well as a
pathological tumour were decided to be very unlikely. Toxicologicalarticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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French Gendarmerie (Institut de Recherche Criminelle de la
Gendarmerie, IRCG) on blood, urine, cerebrospinal ﬂuid and stool
taken on the 1st and 4th of November, 2004, revealed only the
presence of the medication prescribed by the hospital. Further
analyses were performed in urine and faeces on November 8th by
the Radiological Protection Service of the French Armed Forces to
search for radioactive substances based only on gamma emission,
without positive results. The patient developed acute renal failure on
November 6th, 2004. On November 11th, 2004 at 3:30 am, President
Arafat died as a result of cerebral herniation secondary to cerebral
haemorrhage. Despite the number of medical experts involved and
the numerous investigations performed, the pathophysiological
mechanisms at the origin of the group of symptoms experienced by
Yasser Arafat could not be identiﬁed and no autopsy was performed.
According to two letters dated from April 2nd, 2012 and June 11th,
2012 from the Directorate of Radiation Protection of the Army
(Service de Protection Radiologique des Arme´es, France) to our
attention and one letter dated April 2nd, 2012 from the Directorate
of the IRCG to the attention of Mrs Suha Arafat, the biological
samples for toxicological and radio-toxicological analyses that were
taken during his hospitalisation were destroyed in 2008.
Following upon the assassination of Alexander Litvinenko in
London in November 2006 by ingestion of polonium-210 (210Po), a
suggestion was made that Arafat could have been poisoned in a
similar manner. 210Po is a short lived (T1/2 = 138 d) alpha emitter
[2], which typically creates damage on a submillimetre scale,
notably to the gastro-intestinal tract if ingested and then to inner
organs and bone marrow via blood distribution.
On February 2012, Mrs Suha Arafat presented a bag containing
Yasser Arafat’s belongings from his ﬁnal hospital stay, to the
University Centre of Legal Medicine (CURML). She gave us her
consent that we carry out all the necessary toxicological
investigations that could potentially lead to new information
about her late husband’s death. She also gave us a signed letter
giving explicit permission to publication in the scientiﬁc literature
once our Final Expert Forensic Report had been handed to her and
subsequently made public. The Institute of Radiation Physics (IRA)
works in close collaboration with CURML in the use of radiometric
measurements in forensic science [3,4]. The search for 210Po in the
belongings was proposed within the context of current knowledge
regarding Litvinenko’s poisoning. From a medico-legal perspective,
the hypothesis of poisoning with 210Po was justiﬁed given the
absence of a characterised cause of illness and the absence of
toxicological evidence, including gamma radiations. Additionally,
to medico-legal experts, the sudden onset of violent gastrointesti-
nal symptoms following a meal in a patient otherwise in general
good health may indicate poisoning.
After studying the medical ﬁles in detail, we performed a workup
on genetic identiﬁcation as well as toxicology and radioactivity
measurements on Yasser Arafat’s belongings that we received. Our
preliminary results of 210Po identiﬁcation in the biological stains
at unexpected levels of activity [5] led to the exhumation of the
body, which took place in Ramallah on November 27th, 2012. At this
time, several specimens of bones, scalp, shroud, tooth and soil were
taken from the corpse and the grave for toxicological analysis,
focusing mainly on 210Po measurement. We report here the results
of our full investigation concerning Yasser Arafat’s death and the
possible involvement of 210Po as a cause of his death.
2. Materials and methods
2.1. Exhumation procedure
We were requested to act as an expert team for the Palestinian
Authority and Mrs Suha Arafat (hereinafter called the Swiss team).The Swiss team was composed of a medico legal expert, a radiation
physicist, a radiochemist, a forensic anthropologist and a mortuary
technician. A French team, acting on behalf of the French Justice
Department after Suha Arafat launched a court case in Paris, and a
Russian team, acting as an expert team on behalf of the Palestinian
Authority, were also present during the exhumation. The evening
before the opening of the tomb, we perforated a 12 mm diameter
hole through the grave slab to measure the 222Rn gas concentration
(AlphaGuard, Genitron Instruments, Germany). It was essential to
determine the 222Rn air volume activity because 222Rn is the
precursor of diagenetic 210Pb and 210Po which will deposit on the
grave surfaces and possibly contaminate the remains. In fact,
during diagenesis, a bone may accumulate contaminants from the
burial environment, yielding a radionuclide activity that is in
excess of the bone’s biogenically derived activity [4]. The
exhumation took place the following morning, on November
27th, 2012. During the exhumation, the almost completely
skeletonised corpse was not moved, but specimens from the
remains (mainly fragments of bones and scalp) and surrounding
materials (soil and shroud) were collected by a Palestinian medico
legal expert in the presence of representatives from all teams. The
state of Arafat’s remains meant that it was not possible to identify
organs speciﬁcally targeted by polonium such as soft tissues. This
was a major drawback since polonium is not a bone-seeking
radionuclide. All three teams received 20 similar specimens, whose
description can be found in supplementary information (SI)
provided on the website of the journal. As far as we can judge,
tampering with the corpse was impossible before the opening of
the grave and during the manipulation of the remains.
2.2. Genetic identiﬁcation
Genetic analyses were performed on a bone fragment and a
tooth collected during exhumation. The material from the
exhumation was ground and prepared by drilling at low speed.
DNA was then extracted using a phenol/chloroform protocol.
Identical nuclear DNA (nDNA) proﬁles comprising 15 and 13 loci
(NGM Select kit from Life Technologies) were retrieved from the
bone fragment and the tooth, respectively. Those nDNA proﬁles
corresponded to those previously obtained from the belongings of
Yasser Arafat [5].
2.3. Toxicological screening
We selected four human remains sampled during the exhuma-
tion for systematic toxicological analysis, according to interna-
tional recommendations [6]. Gas chromatography coupled to mass
spectrometry (GC–MS) was used for the detection and identiﬁca-
tion of compounds. The specimens were diluted into methanol
before GC–MS analyses (Agilent 5973N). Specimens were also
analyzed after acetylation. Details of the procedure are given in the
SI.
2.4. 210Po determination
To obtain a high activity, which is necessary in case of
poisoning, 210Po is produced artiﬁcially by irradiating a 209Bi
target with neutrons in a nuclear reactor. However, 210Po is also the
decay product of 210Pb (T1/2 = 22 y), a naturally-occurring
radionuclide which is the result of the decay of the natural
radioactive gas 222Rn in the 238U decay chain. When 210Pb
contaminates a sample, 210Po will accompany it with a similar
activity after about 2 years as a radioactive secular equilibrium
establishes between both radionuclides. In this case, 210Po is said to
be supported by 210Pb. In this sense supported 210Po is apparently
of natural origin. In Yasser Arafat’s case, the presence of natural
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which – if present as a poisoning material at the time of death –
would have decreased by more than two million by the time of
exhumation, due to radioactive decay (number of 210Po elapsed
half-lives of 21). The main problem for determining the level of
artiﬁcial 210Po in Yasser Arafat’s remains, buried eight years earlier,
is the potential presence of diagenetic 210Pb and 210Po.The
diagenetic contribution of 210Pb to the total activity of 210Pb is
the contribution that is not the consequence of biological uptake
during life time. The diagenetic activity is solely derived from
accumulation of contaminants from the burial environment. If
diagenesis is present, it will yield a radionuclide activity that is in
excess of the bone’s biogenically derived activity Therefore,
solubility proﬁling was used to remove diagenetic contaminants,
after residual tissue extraction using a basic solution of 1 M NaOH
and mineralization in 10% oxygenated water in a pressurized
microwave digester (Ultraclave IV, Milestone, Germany). Solubility
proﬁling is based on the differential solubility of bone hydroxyl-
apatite from biogenic or diagenetic origin [7]. A soft acidic buffer
(10 ml, ammonium acetate 0.2 M at pH 4.5) was used to remove
layers of potentially contaminated bone hydroxyl-apatite (1.0 g) in
six successive washings. The washing time was 5 min each in an
ultrasonic bath, afterwards the bone matrix was totally dissolved
in 1 M HCl. After six washings, about 10% of the mass of the bone
was removed.
210Po was spontaneously deposited on a silver disk, using its
speciﬁc electrochemical properties. Then the disc was measured
using alpha spectrometry on a PIPS detector (Canberra Alpha
Analyst, France), using a 209Po tracer as an internal standard [4]. To
quantify 210Pb activity, gamma spectrometric measurements were
performed on several grave specimens (soil, bone and shroud)
using a Canberra p-type HPGe well detector (GCW4523, Canberra,
France) in a 4 ml well-geometry. Typically, 210Pb can be quantiﬁed
using gamma-spectrometry if the activity of the sample is above
0.1 Bq. For a lower activity level, determining the 210Pb was carried
out by separating lead from polonium on a strongly basic resin
(Dowex AG1  8, Bio-Rad) because [PoCl6]2 anion is extracted on
the column, while Pb2+ is not. Then, polonium-free 210Pb was left to
rest for at least three months to allow the secular equilibrium to
partially re-establish. After a three month period, 210Po activity
reaches 36% of the initial 210Pb activity and was measured using
alpha spectrometry as described previously.
Several studies dating back to 1963 were used to obtain a
dataset of 210Po reference concentrations in human bones [3,4,8–
11]. For statistics, these reference values were separated into two
sub-sets, the ﬁrst one containing the 210Po data from autopsy
(n = 95) and the second one containing 210Po data from bones
sampled after exhumation or found in the environment, e.g. buried
in soil, coming from forensic cases (n = 36). We compared these
datasets to the dataset of 210Po values found in Yasser Arafat bones
(n = 16).
Unfortunately, an international inter-laboratories comparison
for 210Po determination in bone samples does not exist. Thus, the
quality control was done through the participation to several
international inter-laboratories exercises on 210Po determination
in urine samples organized by the PROCORAD association [12],
using a somewhat similar procedure to the one described above
(2008–2011, n = 5; average bias: 4.2%).
2.5. 210Pb impurity: calculation and analysis
To check for 210Pb impurity in 210Po made by irradiating a
209Bi target, a 3 MBq 210Po source (certiﬁcate n8 9031-OL-501/
13) was bought from the Czech Metrology Institute. Polonium
was separated from lead to authenticate the presence of 210Pb as
an impurity. 210Pb was measured using gamma-spectrometryboth before and after chemical separation and its presence
conﬁrmed by proportional counting of its short half-life (5.01 d)
daughter product 210Bi (Tennelec LB4100w). We also separated
the lead from four bone specimens, two soils and a scalp
subsample to measure the ratio of stable lead 207Pb/206Pb by
mass spectrometry (Element 2, Thermo Scientiﬁc), with an
accuracy better than 0.1% [13]. The rationale for this measure-
ment was that 206Pb is also the daughter product of 210Po, thus
the past presence of a high level of 210Po will yield a lower
207Pb/206Pb ratio after decay.
2.6. Biokinetic calculation
The systemic biokinetic model of polonium proposed by Legett
and Eckerman [14] was implemented in the simulation modeling
tool Ecolego [15] and in SAAM II [16] in order to calculate the
typical retention of 210Po and 210Pb in organs and tissues in case of
intake. Since ingestion is the most probable route of intake for
poisoning, the systemic biokinetic model was coupled to the
human alimentary tract model as described in ICRP Publication
100 [17]. Absorption of 210Po is assumed to occur exclusively from
the small intestine and is characterized by f1 = 0.1 for inorganic
form.
Further details of the radiometric, toxicological, genetic and
statistical tests, as well as the exhumation procedure and
biokinetic calculation procedure can be found in SI.
2.7. Bayesian analysis
Statistical Bayesian analysis is well suited to coherently
combine evidence from various origins, in our case medical
records, toxicological and radiotoxicology measurements, as well
as personal judgements of probability [18]. It ﬁt the goals of the
present forensic expert report, which was to estimate the
probability of occurrence of a unique event and to evaluate all
the evidence in the light of two alternative hypotheses: H0 Mr
Arafat has not been poisoned by 210Po; H1 Mr Arafat has been
poisoned by 210Po. It was not our task to give an estimate of the
probability of H1, which contains too many elements that are out of
our scope. Our task was to evaluate the likelihood ratio (LR):
LR ¼ P EjH1ð Þ
P EjH0ð Þ
where P(EjH1) is the probability of observing a given evidence E if
H1 is true and P(EjH0) is the probability of observing a given
evidence E if H0 is true. We cannot overemphasize that P(EjH1) is
not equal to P(H1jE). The former is the probability of observing a
given evidence E if Mr Arafat has been poisoned by polonium,
whereas the latter is the probability that Mr Arafat has been
poisoned by polonium if we observe evidence E.
The likelihood ratio LR measures the relative strength of
support which evidence E gives to H1. One of the main advantages
of the LR is that it can easily be updated with new evidence: the
updated LR is simply the previous LR multiplied by LR associated
with the new evidence.
3. Results
Before presenting and discussing the results of our analyses
carried out on Yasser Arafat’s remains, it is important to mention
that in a previous study [5], toxicological tests on Yasser Arafat’s
belongings remained negative with only the patient’s medication
and metabolites indentiﬁed, but that 210Po tests were positive on
some specimens, particularly on a possible urine stain on his
underwear (Fig. 1).
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Fig. 1. Polonium alpha spectra of Yasser Arafat’s belongings visually stained by biological ﬂuids (left) and reference samples (right). Reference samples included belongings
from Yasser Arafat that had not been worn and fabric samples from some IRA collaborators kept in an attic in plastic bags for 10 years. Spectra are normalized to the internal
tracer 209Po (50.0  1.0 mBq).
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Yasser Arafat’s worn belongings and Yasser Arafat’s unworn
belongings (p-value <1%) and between Yasser Arafat’s worn
belongings and IRA reference fabrics (p-value <1%). Conversely, no
statistical difference was found between Yasser Arafat’s unworn
belongings (internal references) and our own reference fabrics.
Interestingly, 42% of the 210Po from the most contaminated sample
was supported by 210Pb. Full results of the 210Po and 210Pb
measurements in the belongings can be found in SI of Froidevaux
et al. [5].
These initial ﬁndings prompted the exhumation of Yasser
Arafat’s remains for further toxicological analyses. Genetic
identiﬁcation of the human remains from the grave guaranteed
that all the specimens were from Yasser Arafat. Only Arafat’s
medication and its metabolites were found in the human remains.
The activity of the 222Rn gas in the grave was 12,000 Bq/m3, which
is a value not especially elevated (for instance, our own
measurements in Switzerland performed with the same instru-
mentation led to a mean value of 35,000 Bq/m3 on the Swiss
Plateau and 90,000 Bq/m3 in the Jura Mountains [19]). This level
validates the comparison of the activities of Yasser Arafat’s remains
with the activities of bones from other exhumations. Surface
activity (mBq/cm2) was determined in three soil specimens, in six
shroud fragments, in one scalp fragment and two fragments of a
ﬂat bone (iliac). One of the soil specimens was sampled below the
abdomen cavity; it contained 42% relative humidity (Hr) and had a
strong black colour compared to 26% Hr for a red soil sampled far
from the corpse (reference soil from the front right corner of the
tomb). Thus the stained soil is believed to contain decayed body
ﬂuids. Its surface activity was 30  4 mBq/cm2 whereas the surface
activity of the reference soil was only 1.7  0.3 mBq/cm2. The surface
activities of the shroud and the reference soil (located away from the
corpse) can be considered as representative of samples not
contaminated by the corpse and possibly only exposed to radon
decay product. The mean activity was 3.9  0.7 mBq/cm2. Wax
(decomposed tissues, from 0.5 to 1 mm thickness) was carefully
removed from a surface of the iliac ﬂat bone and its 210Po activity
determined. Wax is known to be a good interceptor of airborne
radioactive particles and parafﬁn wax is used near nuclear installa-
tions to check for radioactive aerosols. Therefore any contamination
of the iliac by 222Rn progeny (210Pb and 210Po) should be concentrated
in the wax coating the bone.
The soil specimen located left from the corpse was not
statistically different, whereas the surface activities of the iliaccrest waxed tissue, the scalp and the black stained soil located
under the abdominal cavity were all signiﬁcantly higher (p-value
<105).
Results are presented in Fig. 2.
210Po and 210Pb were measured in 16 fragments of bone and
results showed that the 210Po was supported by 210Pb, e.g. the
activity of 210Pb was at least equivalent to the activity of 210Po.
Nevertheless, some of Arafat’s bone fragments contained much
higher (up to 20 times) 210Po and 210Pb activities than the reference
bones (Fig. 3). Furthermore, the isotopic ratio of stable 207Pb/206Pb
was lower in the rib and scalp specimens, which were precisely the
specimens with the highest 210Po activity (see SI for details).
The Yasser Arafat results were compared to previously
published autopsy data (4; 8–11). The 210Po activities differed
signiﬁcantly with 8 out of 16 210Po values with a p-value lower
than 1%. To take into account the possibility of diagenesis, even
after solubility proﬁling, the Yasser Arafat dataset was further
compared to the exhumation dataset [3,20,21]. The 210Po activities
differed even more signiﬁcantly, with 15 out of 16 210Po activities
having a p-value lower than 1%.
In addition, several sub-specimens of the iliac crest were
measured. The 210Po activities were found to increase from the
inner part to the outer part of the iliac bone (Fig. 4). In all of the iliac
sub-specimens, 210Po activities were also supported by 210Pb. The
results of all the 210Po and 210Pb measurements carried out in
specimens taken from the grave can be found in Table SI-2.
Since 210Po was supported by 210Pb in all of the measured
specimens, it is possible that the presence of 210Po was natural, in
spite of all the precautions taken to decontaminate the bones.
Nevertheless, diagenesis in Yasser Arafat’s remains should be
lower compared to other exhumed remains because his body was
not buried. It simply rested on a thin layer of 10 cm of soil, wrapped
in a shroud at the time of inhumation. Thus bone specimens were
not spoiled by soil particles and the corpse was protected by the
shroud, at least during the time necessary for the shroud to
decompose. Another explanation could be that 210Pb was present
as a by-product of 210Po production by neutron irradiation, and not
separated from polonium due to the formation of a volatile lead
polonide, PbPo [22,23]. Calculations carried out by the Paul
Scherrer Institute, Switzerland, showed that the production of
some 210Pb during 209Bi activation by neutrons is possible, but with
a very low 210Pb/210Po activity ratio of around 1012, depending on
the 208Pb impurity into the 209Bi target taken into account.
Nevertheless, an impurity of 210Pb at a much higher level was
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The results of the measurements show that 210Pb was present as an
impurity with an activity ratio of 210Pb/210Po of 1.5  107. Only an
elapsed time of 2.5 years is needed to reach an impurity factor of800
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ment that will accumulate in the skeleton ten times more
compared to 210Po [24]. A calculation using a scenario where a
lethal activity of 1 GBq of 210Po was ingested with a 210Pb impurity
ratio of 107, 106 and 105 is presented in Fig. 5.
4. Discussion
4.1. Radioanalytical results
The time elapsed since Yasser Arafat’s death and this study is
eight years. During these eight years, artiﬁcial 210Po in Yasser
Arafat, if present at death, would have decayed by about two
million (number of elapsed 210Po half-lives of 21). This is the major
limitation of our overall forensic report because by the time we
performed our measurements any residual artiﬁcial 210Po has
possibly reached the natural level of activity found in human
bones. Nevertheless, a signiﬁcant activity of 210Po was found in
Yasser Arafat’s belongings and remains. Certain bone specimens,
such as rib, iliac and sternum, had much higher 210Po activity
compared to the published literature on this subject. Thus the
210Po activities found in Yasser Arafat’s remains do not fall within a
normal range of activity for unexposed persons. These ﬁndings are
in accordance with the unexpected level of 210Po previously found10
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factor of 107), 1 kBq (106) and 10 kBq (105). The activities of 210Po and 210Pb
reach equilibrium after about 8.5 years, 7.1 years and 6 years, respectively.in some of Yasser Arafat’s belongings [5]. However, 210Po could not
be attributed unequivocally to the ingestion of an artiﬁcial source
of polonium given that it was supported by the same activity of
210Pb. In this respect, 210Po may appear natural and its presence
explained as the consequence of 222Rn decay within the tomb.
We ruled out this hypothesis as an explanation for the apparent
secular equilibrium between 210Po and 210Pb because a very
careful decontamination process based on solubility proﬁling of
the bone matrix was carried out. During this process, 10% of the
mass of the bone is removed, to expose only inner, and therefore
contamination-free, surfaces. Additionally, most of the bones were
still covered by a thin layer of wax that was mechanically and
chemically removed before solubility proﬁling. This means that the
wax should have been the receptor of diagenetic contamination
rather than the bone structure. In our laboratory, 15 cases of
forensic interest were treated similarly in a previous study and
revealed no such 210Po and 210Pb activities [3] as those found in
Yasser Arafat’s rib, sternum and iliac. In addition, the dataset from
Swift [20] and Ziad et al. [21] contain 210Po measurements of bones
from exhumation that were only decontaminated mechanically,
mainly by abrasion with sand paper; the maximum 210Po activity
measured was 15 mBq/g Ca, a value far below those measured in
Yasser Arafat’s rib, sternum and iliac. In a prior study, we used a
dataset of 20 exhumed vertebrae which had been buried for
20 years, to test the level of diagenesis in the trabecular bones in
contact with soil particles [4]. Without decontamination, the
maximum activity found in bone with strong diagenetic contami-
nation was 300 mBq/g Ca, an activity which lowered further to
36 mBq/g Ca after 6 washings with acetate buffer. Once again, no
210Po activity such as those measured in Yasser Arafat’s remains
was found. Another ﬁnding points to a biogenic origin of 210Po and
210Pb; strong heterogeneity was found in the activities measured
along an inner-outer transect in the iliac bone, with a steady
increase in activity from the inner to the outer part (Fig. 4).
Additionally, only highly vascularised bones such as the iliac, rib
and sternum contained very signiﬁcant 210Pb–210Po activity, while
cortical bone such as the femur had somewhat close to background
activity. This ﬁnding is not compatible with a diagenetic origin of
210Pb–210Po but matches a distribution pattern coherent with an
incorporation of a bone-seeking element shortly before death [24].
While we do not put emphasis on the results of the stable
207Pb/206Pb ratio because of large uncertainties in the measure-
ment, the trend of low ratio values for the two specimens with the
highest measured 210Po activities might indicate the presence of a
high 210Po level in the past.
Additionally, if the 210Po and 210Pb measured in the body were
of a diagenetic origin, similar surface activities on the reference soil
and the shroud would be expected on the one hand, and on the
black stained soil and the scalp on the other hand. This was not the
case and the latter values are signiﬁcantly higher. Therefore, and
knowing that the activity concentration of 222Rn measured before
opening the tomb was relatively low for a soil, we are conﬁdent
that the 210Po and 210Pb measured in this study are of biogenic
origin.
Nevertheless, the question remains regarding the provenance of
210Pb in Yasser Arafat’s bones. We measured a commercial 210Po
source of 3 MBq and found it to contain a signiﬁcant activity of
210Pb impurity able to explain the high 210Po and 210Pb activities
found in Yasser Arafat’s remains, as well as the presence of a
secular equilibrium between 210Po and 210Pb eight years after
death. Furthermore, 210Pb is a bone-seeker and has a long half-life
of 22 years. Its presence as an impurity in a 210Po ingested source
will leave a 210Pb–210Po trace for much longer than 210Po alone, as
was demonstrated using a biokinetic calculation (Fig. 5). Addition-
ally, there is strong evidence that 210Pb may be a signiﬁcant
impurity in a 210Po source made by irradiation of 209Bi.
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As already mentioned, the assassination of Alexander Litvi-
nenko represents the only openly documented 210Po poisoning
case. Although it has not been described in the conventional
scientiﬁc literature, the evidence from the Litvinenko case have
been made public on the internet [25]. The inquiry showed that Mr
Litvinenko’s contamination probably resulted from one substantial
intake, although the results of autoradiography measurements of
alpha emitter performed on his hair suggest that a much smaller
contamination may have occurred a couple of days earlier
[26,27]. The ﬁrst reported symptoms were vomiting and diarrhoea,
together with abdominal pain followed by alopecia and myelo-
suppression. Then multiple organ failure, including kidney and
liver deﬁciencies, led to his death.
Comparatively, Yasser Arafat’s medical records essentially
showed gastrointestinal symptoms at the onset, followed by liver
and renal damage and ended with multiple organ failure. Multiple
organ failure is, however, a non-speciﬁc ﬁnal issue that can
frequently not be attributed to a speciﬁc triggering event. Although
mild myelodysplastic changes of the bone marrow were found
about two weeks after the ﬁrst symptoms, myelosuppression and
alopecia were not observed in Yasser Arafat. At ﬁrst glance, this
striking difference between the two medical records suggests
polonium poisoning in the case of Yasser Arafat must be ruled out.
However, before drawing a deﬁnite conclusion, it is important to
take into account the difference between external irradiation and
radionuclide intake, and how the time delivery-scheme of intake
could affect the observed symptoms.
Ionizing radiations, including gamma rays and alpha particles
are known to damage biological molecules, including DNA. 210Po is
an alpha emitter, which is particularly destructive at the cellular
level as alpha particles deposit all their energy within tens of
micrometers. Therefore, radiological damages induced by 210Po are
not uniform within the whole body, because they are directly
related to the location of the individual polonium atoms, which is
deﬁned by their speciﬁc biokinetic. This is very different than
external irradiation with penetrating radiation, like photons or
neutrons that tend to produce relatively homogenous dose
deposition within all exposed organs. While persons exposed to
high doses of external irradiation tend to develop haematopoietic,
gastrointestinal, cardiovascular, central nervous system and skin
reactions, the reaction following the intake of alpha-emitting
nuclides may be very different and is much less documented. In the
case of 210Po intake, the toxicity is inﬂuenced by the speciﬁc tissue
sensitivities and the accumulation of the radionuclide in the
different organs.
After ingestion of 210Po, it is considered that the gut is the
primary target for the initiation of prodromal responses, including
vomiting and diarrhoea [28]. The toxic substance is then absorbed
into the blood (f1 = 10%) and redistributed to the organs where it
can be incorporated and distributed, mainly to the liver and the
kidneys [14,29].
Tissue effects depend on the organ and have a dose threshold
that varies from person to person, and below which nothing is
detectable without conducting a clinical test. This means that
depending on the amount of intake and its time delivery-scheme
the organs that show an effect could vary. For 210Po, the available
animal and human data indicate that a sufﬁciently high intake can
lead to death after multiple organ failure. For lower intakes, animal
studies have shown protracted effects resulting only in kidney
damage and then death [27]. Other animal studies have shown that
low intakes did not provoke haematological abnormalities and that
only mild kidney lesions could be noticed [29,30]. The same studies
also showed that the initially observed damage to the bone
marrow could be followed by an active regeneration.All these considerations allow us now to examine the
plausibility of observing the reported symptoms of Mr Arafat in
light of 210Po poisoning. In this forensic context, we considered
different possible time delivery-schemes. We will therefore
discuss in the next paragraphs two situations: one in which a
single high activity was ingested and another in which smaller
activities were ingested repeatedly.
The fact that myelosuppression and hair loss are missing in Mr
Arafat’s case does not support a single high activity intake of 210Po.
However, side-effects observed with high activities injected or
ingested in nuclear medicine therapy include nausea, vomiting,
fatigue and abdominal pain, but less frequently hair loss. Further-
more, myelosuppression varies greatly among patients treated
either with beta-emitters [31] or alpha-emitters [32]. As a matter of
fact, the extent of myelosuppression to be expected following
intakes of radionuclides will differ according to their chemical and
physical characteristics. For example, the effect of alpha particles
emitted from radium isotopes deposited in bone mineral will be
limited mainly to peripheral marrow and other parts of the marrow
will be unaffected. Recent treatments with bone-seeking alpha-
emitters such as 223Ra conﬁrmed that myelosuppression was then
minimal [32,33]. According to the ICRP intake model, 210Po tends to
be deposited on the bone surface during the ﬁrst month after intake.
Because of the short range of alpha particles, the dose delivered from
the bone surface to the active marrow is highly heterogeneous and
large fractions of the active marrow are spared [33]. The uptake of
210Po on the bone surface is thus not expected to systematically
cause severe myelosuppression. It is then only the amount of 210Po
absorbed into the blood that contributes to the bone marrow dose.
All this considered, the absence of myelosuppression and hair loss
does not support a single high intake of 210Po but does not exclude
the possibility.
In the scenario of repeated intakes of small 210Po activity, we
can picture that the ‘‘last straw’’ trigged the clinical symptoms,
which were subclinical after previous intakes. In Yasser Arafat’s
case, low marrow cellularity (i.e. increased adipocyte concentra-
tion) associated with aging might also have attenuated the
myelosuppression. Indeed, as marrow cellularity decreases, alpha
particles increasingly encounter adipocytes and the energy
deposited into active marrow is thus decreased [34]. This could
potentially reduce myelosuppression in the elderly. It is also
possible that the intake could be too low to damage the red bone
marrow or that the transiting damage could recover during the
interval between two successive intakes as it was observed in
animal studies [30]. The same argument could possibly explain the
absence of hair loss through recovery of the skin basal cells.
As already mentioned, the alimentary tract is considered to be
the primary radiation target of 210Po involving the release of a
neurotransmitter from intestinal cells that activates the brain-
vomiting centre [26]. This is further supported by the fact that the
present biokinetic model probably underestimates the dose as it
does not take into account the possibility of retention in the
gastrointestinal tracts [28]. This explains the presence of vomiting
and diarrhea in the Litvinenko case. For Yasser Arafat, no
explanations for these observed symptoms were found despite
very extensive clinical investigations. Harrison et al. [28] also
reported results from a rat study suggesting that damage to the gut
mucosa was the possible cause of death in a case of ingestion of
210Po. After ingestion of 210Po, the gastrointestinal syndrome,
associated with multiple organ failure, could therefore be a
predominant cause of death [35,36].
4.3. Russian forensic expert report
Two other teams also took part in the exhumation of Yasser
Arafat and analyzed similar samples: a French team commissioned
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sioned by the Palestinian Authority. Contrary to the French, the
Russians published their results [37]. Their analytical results were
very similar to our measurements. They also measured bone
activities of 210Po and 210Pb at equilibrium that were much higher
than normal. They tested two hypotheses: contamination by radon
in the tomb and ingestion of a 210Pb source shortly before death.
They rejected both hypotheses and concluded that ‘‘unfortunately,
it is not possible to state clearly the cause of the 210Pb radionuclide
presence in the samples only on the basis of the physical research
results’’. Concerning the medical ﬁle, they considered that 210Po
poisoning should have led to a full spectrum of acute radiation
syndrome. Speciﬁcally, they were expecting myelosuppression
and hair loss. They did not take into account our measurements on
the personal belongings [5] and concluded that ‘‘a direct causal link
between the presence of high content of [210Po and 210Pb] in the
remains of the deceased and his death should be excluded’’.
4.4. Bayesian analysis
The evidences gathered during this expert report are not clear-
cut: we cannot exclude 210Po as a cause of death, but we cannot be
sure that 210Po was the cause of death. We have three main
contributions to take into account for calculating LR: the
measurements performed on the belongings, the measurements
performed on the exhumed body remains, and the analysis of the
medical ﬁles. We estimate each contribution separately.
The measurements performed on the personal effects showed
large quantities of unsupported 210Po associated with the presence
of biological ﬂuids. Although this has been published for two years
[5], no alternative explanation to polonium poisoning has been
proposed.
The measurements performed on the remains showed a high
quantity of supported 210Po but were about 20 times higher than
all other exhumed cadavers documented in the scientiﬁc literature.
These high activities cannot be explained by the presence of radon
in the tomb but are coherent with the ingestion of a 210Po source
containing an impurity of 210Pb akin to what we measured in a
commercial source.
Concerning the medical ﬁle, the situation is similar. Yasser
Arafat did not show all possible symptoms observed in the case of
acute radiation syndrome. In particular, no myelosuppression and
no hair loss were documented. In a forensic expert report, we have
to factor in the variability of reactions that are probably present.
For instance, Mr Arafat was 32 years older than Mr Litvinenko at
the time of their deaths. Mr Litvinenko lost his hair and showed a
clear myelosuppression, but, as discussed before, this is not always
documented in radiation therapy patients of nuclear medicine. If
we open the range of possible poisoning scenarios, we should also
consider possible repeated smaller intakes. As mentioned above,
this type of scenario could lead to gastro-intestinal symptoms that
could appear once a certain threshold has been exceeded and then
develop into multiple organ failure.
We can now process all this information using a Bayesian
analysis, and estimate the LRs associated with each piece of
evidence. We estimated that the LR of high activity of unsupported
210Po in the personal belongings is larger than one: in other words,
it is more likely to observe unsupported 210Po in the biological
stains if Mr Arafat had been poisoned than if he had not. For the
high activities of supported 210Po found in the remains, the LR is
also larger than one because, to our knowledge, no documented
cadaver has been measured with such an activity. Furthermore, no
plausible alternative explanation has been proposed and the
presence of a small impurity of 210Pb in a 210Po source could lead
to what has been observed in Mr Arafat’s bones. The medical ﬁle
analysis points toward the opposite, because of the differencesbetween Mr Arafat and Mr Litvinenko. Consequently, we estimated
that the corresponding LR is smaller than one. However, LR is
certainly not zero because a repeated series of small intakes of
210Po or a speciﬁc weaker cellular reaction of Mr Arafat could also
explain the observed symptoms and, mostly, because the Percy
Hospital physicians did not ultimately identify the cause of Yasser
Arafat’s death.
Putting all of this together, we estimate that the LR associated
with the medical ﬁle is not small enough to compensate the
relatively large LRs associated with the measurements on Mr
Arafat’s personal belongings and remains. Therefore, we have to
deduce that our radiotoxicology analyses and the observed medical
symptoms support the proposition that Mr Arafat was poisoned
by 210Po. This support is maybe not strong, but certainly not slight.
5. Conclusions
Despite extensive clinical investigations, the cause of the
gastrointestinal symptoms followed by multiple organ failure
developed by Yasser Arafat was not determined at time of his
death. Our study presents analytical results that support the
hypothesis of 210Po poisoning essentially on the basis of
unexplained 210Po activities found in Yasser Arafat’s belongings
worn shortly before his death and on unexplained 210Pb and 210Pb
activities found in his remains.
Alexander Litvinenko’s case is at this time the only documented
case related to acute radiation syndrome following upon 210Po
malicious administration. The comparison of these two cases
showed clinical similarities except for alopecia and myelosuppres-
sion experienced by Alexander Litvinenko. Nevertheless, this
difference is not an argument to exclude with sufﬁcient certitude
the hypothesis of 210Po poisoning if we consider that the
administration scheme could have been different in the two
cases: an acute poisoning by administration of a substantial dose
versus poisoning by the repetition of smaller doses. Moreover, it
should also be taken into account all possible interfering factors
such as age, previous health status and genetic predisposition—all
of which could lead to different symptoms.
In conclusion, even if our ﬁndings reasonably support the
hypothesis of 210Po poisoning, Yasser Arafat’s cause of death will
probably remain a cold-case.
Role of funding sources
There are no ﬁnancial or other relations that could lead to a
conﬂict of interest. However, the costs of the analyses were
covered in equal part by Mrs. Suha Arafat and the Palestinian
Authority (PA). In addition, due to security concerns, the PA
accommodated the Swiss team during its stay in Ramallah. Neither
Mrs. Suha Arafat, nor the PA had a role in study design, data
gathering, data analysis, data interpretation, or writing of the
report. All the other costs of the expertise were covered internally
by the Lausanne University Hospital. The Expert Forensic Report
concerning the Late President Arafat that we wrote in our quality of
Swiss Experts Team was handed jointly to both Mrs. Suha Arafat
(represented by her legal counsel) and to the PA ofﬁcials during a
meeting in Geneva, November 5th, 2013. The corresponding
author had full access to all the data in the study and had ﬁnal
responsibility for the decision to submit for publication.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.forsciint.2015.09.
019.
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